98%
921
2 minutes
20
Introduction: Molecular classifiers are a promising tool to refine the diagnosis of antibody-mediated rejection (ABMR) and T-cell-mediated rejection (TCMR) after kidney transplantation. Despite this potential, the integration of molecular classifiers in transplant clinics has been slow, in part because of the complexity of current assays and lack of a consensus platform. Herein, we aimed to develop and validate sparse molecular classifiers for ABMR and TCMR using allograft tissue.
Methods: In a discovery cohort of 224 kidney transplant biopsies, lasso regression was applied on microarray gene expression data to derive a molecular classifier for ABMR and TCMR, respectively.
Results: A 2-gene classifier for ABMR (, and a 2-gene classifier for TCMR (, were identified. External validation ( = 403 biopsies) demonstrated preserved diagnostic accuracy for ABMR (area under the receiver operating characteristic curve [ROC-AUC]: 0.80, 95% confidence interval [CI]: 0.75-0.85) and TCMR (ROC-AUC: 0.83, 95% CI: 0.77-0.89), with the possibility to discriminate between pure and mixed rejection phenotypes. Complementary to their diagnostic potential, the molecular classifiers associated with accelerated graft loss in a second validation cohort ( = 282 biopsies) and identified allografts at risk for failure with histological lesions that did not reach the Banff thresholds for rejection. The computational approach was further validated using the Banff Human Organ Transplant (B-HOT) gene panel in 2 independent biopsy cohorts that were analyzed on the Nanostring nCounter platform ( = 66 and = 80, respectively).
Conclusion: Rigid variable selection strategies can yield sparse molecular classifiers for allograft rejection phenotypes with preserved accuracy and prognostic value across different molecular diagnostic platforms, which may facilitate their interpretation and clinical implementation.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC12231026 | PMC |
http://dx.doi.org/10.1016/j.ekir.2025.03.048 | DOI Listing |
Eur J Nucl Med Mol Imaging
September 2025
Department of Nuclear Medicine, University Hospital Münster, Albert-Schweitzer-Campus 1, 48149, Münster, Germany.
Purpose: Amino acid PET with [F]-fluoroethylthyrosine ([F]FET-PET) is frequently utilized in gliomas. Most studies on prognostication based on amino acid PET comprise mixed cohorts of brain tumors with low- and high-grade features. The objective of this study was to assess the potential prognostic value of [F]FET-PET-based markers in the group of grade 2 adult-type diffuse gliomas, as defined by the WHO CNS 2021 classification.
View Article and Find Full Text PDFEye (Lond)
September 2025
Genetics Laboratory, Metropolitan South Clinical Laboratory, Bellvitge University Hospital, Institut d'Investigació Biomèdica de Bellvitge (IDIBELL), L'Hospitalet de Llobregat, Barcelona, Spain.
Background: Inherited retinal dystrophies (IRDs) are a genetically heterogeneous group of conditions, with approximately 40% of cases remaining unresolved after initial genetic testing. This study aimed to assess the impact of a personalised genomic approach integrating whole-exome sequencing (WES) reanalysis, whole-genome sequencing (WGS), customised gene panels and functional assays to improve diagnostic yield in unresolved cases.
Subjects/methods: We retrospectively reviewed a cohort of 597 individuals with IRDs, including 525 probands and 72 affected relatives.
Cell Death Discov
September 2025
Department of Molecular Oncology, King Faisal Specialist Hospital & Research Centre, Riyadh, Saudi Arabia.
Ado-trastuzumab is considered a standard treatment for patients with HER2+ metastatic breast cancer (mBC). Current clinical practices do not reliably predict therapeutic outcomes for patients who are refractory to therapy. Long noncoding RNAs (lncRNAs) are emerging as critical regulators of gene expression and therapeutic resistance, and the use of lncRNAs as tumor biomarkers is becoming more common in other diseases.
View Article and Find Full Text PDFThe genus Flapocephalus Deshmukh, 1979, is a little-known group of lecanicephalidean cestodes parasitizing cowtail rays (genus Pastinachus Rüppell) mainly in the Indo-Pacific region. Since the erection of the genus, with Flapocephalus trygonis Deshmukh, 1979, as the type species, and the description of a second species, Flapocephalus saurashtri Shinde and Deshmukh, 1979, both from Pastinachus sephen (Fabricius) from India, reports of this genus have been restricted mainly to brief mentions or discussion of its validity and taxonomic placement. More recently, phylogenetic analyses based on molecular sequence data that included specimens of Flapocephalus have supported Flapocephalus as a distinct genus allied with the Polypocephalidae Meggitt, 1924.
View Article and Find Full Text PDFProc Biol Sci
September 2025
Oxford University Museum of Natural History, University of Oxford, Parks Road, Oxford OX1 3PW, UK.
Hemiptera, the fifth most diverse insect order, are characterized by their high diversity in deep time, with 145 known extinct families. However, the precise timing of the origin of Hemiptera lineages has remained uncertain. Traditional approaches, molecular clock analyses and fossil calibrations, have overlooked much of this extinct diversity by failing to incorporate key fossil data.
View Article and Find Full Text PDF